特集: 調査項目の変更・追加が可能なセミカスタムオーダー型の調査レポート(Lucintel社)はこちら

特集 : 国別の市場調査レポートをお探しの方はこちら

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の自家ワクチン市場:動物の病気撲滅と予防接種の向上のための資金調達の増加

Global Market Study on Autogenous Vaccines: Increasing Funding for Animal Disease Eradication and Immunization Propelling Growth

発行 Persistence Market Research 商品コード 925999
出版日 ページ情報 英文 176 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.13円で換算しております。
世界の自家ワクチン市場:動物の病気撲滅と予防接種の向上のための資金調達の増加 Global Market Study on Autogenous Vaccines: Increasing Funding for Animal Disease Eradication and Immunization Propelling Growth
出版日: 2020年01月24日 ページ情報: 英文 176 Pages
概要

当レポートは世界の自家ワクチン市場について調査しており、市場動向や機会、需要分析、成長および阻害要因、菌株タイプ・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の概要

  • 市場調査範囲/分類
  • 市場の定義/範囲/制限

第3章 主な市場動向

第4章 市況

  • 規制シナリオ
  • 親市場分析

第5章 市場需要分析および予測

  • 過去の市場分析
  • 現在/今後の市場予測
    • 前年比成長動向分析

第6章 市場の背景

  • マクロ経済要因
  • 予測要因:関連性と影響
  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会分析

第7章 市場分析:菌株タイプ別

  • 概要/主な調査結果
  • 過去の市場と分析
  • 現在/今後の市場分析および予測
    • 細菌株
    • ウイルス株
  • 市場の魅力分析

第8章 市場分析:エンドユーザー別

  • 概要/主な調査結果
  • 過去の市場分析
  • 現在/今後の市場分析と予測
    • 獣医クリニック
    • 動物病院
    • 獣医研究所
  • 市場の魅力分析

第9章 市場分析:地域別

  • イントロダクション
  • 過去の市場分析
  • 現在の市場分析と予測
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ(MEA)
  • 市場の魅力分析

第10章 北米

第11章 ラテンアメリカ

第12章 欧州

第13章 南アジア

第14章 東アジア

第15章 オセアニア

第16章 中東およびアフリカ

第17章 新興国

  • 概要
  • 中国
  • インド
  • ブラジル

第18章 市場構造分析

第19章 競争分析

  • 競合ダッシュボード
  • 企業プロファイル
    • Newport Laboratories, Inc. (Boehringer Ingelheim International GmbH)
    • Elanco Animal Health
    • Ceva (Ceva Biovac)
    • Cambridge Technologies
    • Hygieia Biological Laboratories
    • Dyntec s. r. o
    • Phibro Animal Health Corporation
    • Huvepharma, Inc.
    • Deltamune
    • AniCon Labor GmbH
    • ACE Laboratory Services (Apiam Animal Health)

第20章 使用される前提条件・略語

第21章 調査方法

図表

List of Table

  • Table 01: Global Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Table 02: Global Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 03: Global Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region
  • Table 04: North America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 05: North America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Table 06: North America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 07: Latin America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 08: Latin America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Table 09: Latin America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 10: Europe Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 11: Europe Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Table 12: Europe Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 13: South Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 14: South Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Table 15: South Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 16: East Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 17: East Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Table 18: East Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 19: Oceania Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 20: Oceania Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Table 21: Oceania Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 22: MEA Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 23: MEA Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Table 24: MEA Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 25: China Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Table 26: China Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 27: India Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Table 28: India Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Table 29: Brazil Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Table 30: Brazil Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User

List of Figure

  • Figure 01: Global Autogenous Vaccines Market Value Share, by Strain Type (2019E)
  • Figure 02: Global Autogenous Vaccines Market Value Share, by End User (2019E)
  • Figure 03: Global Autogenous Vaccines Market Value Share, by Region (2019E)
  • Figure 04: Global Autogenous Vaccines Market Size (US$ Mn) Analysis, 2014-2018
  • Figure 05: Global Autogenous Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2019-2029
  • Figure 06: Global Autogenous Vaccines Market Absolute $ Opportunity Analysis, 2019-2029
  • Figure 07: Global Autogenous Vaccines Market Analysis by Strain Type -2019 & 2029
  • Figure 08: Global Autogenous Vaccines Market Y-o-Y Growth Projections by Strain Type, 2019 - 2029
  • Figure 09: Global Autogenous Vaccines Market Attractiveness Analysis by Strain Type, 2019-2029
  • Figure 10: Global Autogenous Vaccines Market Analysis by End User -2019 & 2029
  • Figure 11: Global Autogenous Vaccines Market Y-o-Y Growth Projections by End User, 2019 - 2029
  • Figure 12: Global Autogenous Vaccines Market Attractiveness Analysis by End User, 2019-2029
  • Figure 13: Global Autogenous Vaccines Market Analysis by Region -2019 & 2029
  • Figure 14: Global Autogenous Vaccines Market Y-o-Y Growth Projections by Region, 2019 - 2029
  • Figure 15: Global Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region
  • Figure 16: North America Autogenous Vaccines Market Value Share Analysis (%), By Strain Type, 2018A
  • Figure 17: North America Autogenous Vaccines Market Value Share Analysis (%), By End User, 2018A
  • Figure 18: North America Autogenous Vaccines Market Value Share Analysis (%), By Country, 2018A
  • Figure 19: North America Autogenous Vaccines Market Size (US$ Mn) Analysis, 2014-2018
  • Figure 20: North America Autogenous Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2029
  • Figure 21: North America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Figure 22: North America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Figure 23: North America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Figure 24: Latin America Autogenous Vaccines Market Value Share Analysis (%), By Strain Type, 2018A
  • Figure 25: Latin America Autogenous Vaccines Market Value Share Analysis (%), By End User, 2018A
  • Figure 26: Latin America Autogenous Vaccines Market Value Share Analysis (%), By Country, 2018A
  • Figure 27: Latin America Autogenous Vaccines Market Size (US$ Mn) Analysis, 2014-2018
  • Figure 28: Latin America Autogenous Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2029
  • Figure 29: Latin America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Figure 30: Latin America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Figure 31: Latin America Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Figure 32: Europe Autogenous Vaccines Market Value Share Analysis (%), By Strain Type, 2018A
  • Figure 33: Europe Autogenous Vaccines Market Value Share Analysis (%), By End User, 2018A
  • Figure 34: Europe Autogenous Vaccines Market Value Share Analysis (%), By Country, 2018A
  • Figure 35: Europe Autogenous Vaccines Market Size (US$ Mn) Analysis, 2014-2018
  • Figure 36: Europe Autogenous Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2029
  • Figure 37: Europe Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Figure 38: Europe Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Figure 39: Europe Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Figure 40: South Asia Autogenous Vaccines Market Value Share Analysis (%), By Strain Type, 2018A
  • Figure 41: South Asia Autogenous Vaccines Market Value Share Analysis (%), By End User, 2018A
  • Figure 42: South Asia Autogenous Vaccines Market Value Share Analysis (%), By Country, 2018A
  • Figure 43: South Asia Autogenous Vaccines Market Size (US$ Mn) Analysis, 2014-2018
  • Figure 44: South Asia Autogenous Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2029
  • Figure 45: South Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Figure 46: South Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Figure 47: South Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Figure 48: East Asia Autogenous Vaccines Market Value Share Analysis (%), By Strain Type, 2018A
  • Figure 49: East Asia Autogenous Vaccines Market Value Share Analysis (%), By End User, 2018A
  • Figure 50: East Asia Autogenous Vaccines Market Value Share Analysis (%), By Country, 2018A
  • Figure 51: East Asia Autogenous Vaccines Market Size (US$ Mn) Analysis, 2014-2018
  • Figure 52: East Asia Autogenous Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2029
  • Figure 53: East Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Figure 54: East Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Figure 55: East Asia Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Figure 56: Oceania Autogenous Vaccines Market Value Share Analysis (%), By Strain Type, 2018A
  • Figure 57: Oceania Autogenous Vaccines Market Value Share Analysis (%), By End User, 2018A
  • Figure 58: Oceania Autogenous Vaccines Market Value Share Analysis (%), By Country, 2018A
  • Figure 59: Oceania Autogenous Vaccines Market Size (US$ Mn) Analysis, 2014-2018
  • Figure 60: Oceania Autogenous Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2029
  • Figure 61: Oceania Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Figure 62: Oceania Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Figure 63: Oceania Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Figure 64: MEA Autogenous Vaccines Market Value Share Analysis (%), By Strain Type, 2018A
  • Figure 65: MEA Autogenous Vaccines Market Value Share Analysis (%), By End User, 2018A
  • Figure 66: MEA Autogenous Vaccines Market Value Share Analysis (%), By Country, 2018A
  • Figure 67: MEA Autogenous Vaccines Market Size (US$ Mn) Analysis, 2014-2018
  • Figure 68: MEA Autogenous Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2029
  • Figure 69: MEA Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Figure 70: MEA Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Figure 71: MEA Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Figure 72: Global Autogenous Vaccines Market Value Proportion Analysis, By Emerging Countries, 2018
  • Figure 73: Autogenous Vaccines Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2018-2029
  • Figure 74: China Autogenous Vaccines Market Value Share Analysis (%), By Strain Type, 2018A
  • Figure 75: China Autogenous Vaccines Market Value Share Analysis (%), By End User, 2018A
  • Figure 76: China Autogenous Vaccines Market Size (US$ Mn) Analysis, 2014-2018
  • Figure 77: China Autogenous Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2029
  • Figure 78: China Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Figure 79: China Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Figure 80: India Autogenous Vaccines Market Value Share Analysis (%), By Strain Type, 2018A
  • Figure 81: India Autogenous Vaccines Market Value Share Analysis (%), By End User, 2019E
  • Figure 82: India Autogenous Vaccines Market Size (US$ Mn) Analysis, 2014-2018
  • Figure 83: India Autogenous Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2029
  • Figure 84: India Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Figure 85: India Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
  • Figure 86: Brazil Autogenous Vaccines Market Value Share Analysis (%), By Strain Type, 2018A
  • Figure 87: Brazil Autogenous Vaccines Market Value Share Analysis (%), By End User, 2019E
  • Figure 88: Brazil Autogenous Vaccines Market Size (US$ Mn) Analysis, 2014-2018
  • Figure 89: Brazil Autogenous Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2029
  • Figure 90: Brazil Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Strain Type
  • Figure 91: Brazil Autogenous Vaccines Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
目次

Autogenous Vaccines Market: Scope of the Report

Persistence Market Research (PMR) recently published a study on the global autogenous vaccines market. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the autogenous vaccines market structure. The market study presents exclusive information about how the autogenous vaccines market will grow during the forecast period of 2019-2029.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in PMR's study in a comprehensive manner. Other information includes pricing analysis by region and by product type, which helps in deep understanding of the pricing details by researchers, suppliers, manufactures, and distributors. The other information contains volume analysis, which includes year wise growth of autogenous vaccines during the forecast period. This information can help readers understand the quantitative growth prospects of the autogenous vaccines market during the forecast period.

The study is relevant for manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researcher, shareholders, industry experts can leverage the information and data presented in PMR's study.

The study also includes statistics as well as facts related to macroeconomics factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the autogenous vaccines market. Furthermore, small businesses and new entrants in the autogenous vaccines market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.

Key Questions Answered in PMR's Autogenous Vaccines Market Report

Which regions will continue to remain the most profitable regional markets for autogenous vaccines market players?

Which factors will induce a change in the demand for autogenous vaccines during the assessment period?

What are the different opportunities available for emerging players in the autogenous vaccines market?

How are supply-side and demand-side drivers impacting the autogenous vaccines market?

How will changing trends impact the autogenous vaccines market?

How can market players capture the low-hanging opportunities in the autogenous vaccines market in developed regions?

Which companies are leading the autogenous vaccines market?

What are the winning strategies of stakeholders in the autogenous vaccines market to upscale their position in this landscape?

Autogenous Vaccines Market: Research Methodology

In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the autogenous vaccines market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analyst ensure accuracy and reliability of conclusions.

Secondary resources referred to analyst during the production of the autogenous vaccines market study include statistics from government healthcare organizations, medicines journals, research journals, press release, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the autogenous vaccines market, and makes PMR's projection on the growth prospects of the autogenous vaccines market more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

4. Market Context

  • 4.1. Regulatory Scenario
  • 4.2. Parent Market Analysis

5. Global Autogenous Vaccines Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

  • 5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
  • 5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
    • 5.2.1. Y-o-Y Growth Trend Analysis
    • 5.2.2. Absolute $ Opportunity Analysis

6. Market Background

  • 6.1. Macro-Economic Factors
  • 6.2. Forecast Factors - Relevance & Impact
  • 6.3. Market Dynamics
    • 6.3.1. Drivers
    • 6.3.2. Restraints
    • 6.3.3. Opportunity Analysis

7. Global Autogenous Vaccines Market Analysis 2014-2018 and Forecast 2019-2029, by Strain Type

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) & Volume (Mn Units) Analysis By Strain Type, 2014 - 2018
  • 7.3. Current and Future Market Size (US$ Mn) & Volume (Mn Units) Analysis and Forecast By Strain Type, 2019 - 2029
    • 7.3.1. Bacterial Strain
    • 7.3.2. Virus Strain
  • 7.4. Market Attractiveness Analysis By Strain Type

8. Global Autogenous Vaccines Market Analysis 2014-2018 and Forecast 2019-2029, by End User

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 - 2018
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019 - 2029
    • 8.3.1. Veterinary Clinics
    • 8.3.2. Veterinary Hospitals
    • 8.3.3. Veterinary Research Institutes
  • 8.4. Market Attractiveness Analysis By End User

9. Global Autogenous Vaccines Market Analysis 2014-2018 and Forecast 2019-2029, by Region

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. East Asia
    • 9.3.5. South Asia
    • 9.3.6. Oceania
    • 9.3.7. Middle East & Africa (MEA)
  • 9.4. Market Attractiveness Analysis By Region

10. North America Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
  • 10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
    • 10.3.1. By Country
      • 10.3.1.1. U.S.
      • 10.3.1.2. Canada
    • 10.3.2. By Strain Type
    • 10.3.3. By End User
  • 10.4. Market Attractiveness Analysis
    • 10.4.1. By Country
    • 10.4.2. By Strain Type
    • 10.4.3. By End User

11. Latin America Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
  • 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
    • 11.3.1. By Country
      • 11.3.1.1. Brazil
      • 11.3.1.2. Mexico
      • 11.3.1.3. Rest of Latin America
    • 11.3.2. By Strain Type
    • 11.3.3. By End User
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Strain Type
    • 11.4.3. By End User

12. Europe Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
    • 12.3.1. By Country
      • 12.3.1.1. Germany
      • 12.3.1.2. Italy
      • 12.3.1.3. France
      • 12.3.1.4. U.K.
      • 12.3.1.5. Spain
      • 12.3.1.6. BENELUX
      • 12.3.1.7. Russia
      • 12.3.1.8. Rest of Europe
    • 12.3.2. By Strain Type
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Strain Type
    • 12.4.3. By End User

13. South Asia Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
    • 13.3.1. By Country
      • 13.3.1.1. India
      • 13.3.1.2. Thailand
      • 13.3.1.3. Indonesia
      • 13.3.1.4. Malaysia
      • 13.3.1.5. Rest of South Asia
    • 13.3.2. By Strain Type
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Strain Type
    • 13.4.3. By End User

14. East Asia Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
  • 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
    • 14.3.2. By Strain Type
    • 14.3.3. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Strain Type
    • 14.4.3. By End User

15. Oceania Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
  • 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
    • 15.3.1. By Country
      • 15.3.1.1. Australia
      • 15.3.1.2. New Zealand
    • 15.3.2. By Strain Type
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Strain Type
    • 15.4.3. By End User

16. Middle East and Africa Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
  • 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
    • 16.3.1. By Country
      • 16.3.1.1. GCC Countries
      • 16.3.1.2. Turkey
      • 16.3.1.3. Northern Africa
      • 16.3.1.4. South Africa
      • 16.3.1.5. Rest of Middle East and Africa
    • 16.3.2. By Strain Type
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Strain Type
    • 16.4.3. By End User

17. Emerging Countries Autogenous Vaccines Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

  • 17.1. Introduction
    • 17.1.1. Market Value Proportion Analysis, By Key Countries
    • 17.1.2. Global Vs. Country Growth Comparison
  • 17.2. China Autogenous Vaccines Market Analysis
    • 17.2.1. Introduction
    • 17.2.2. Market Value Proportion Analysis by Market Taxonomy
    • 17.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 17.2.3.1. By Strain Type
      • 17.2.3.2. By End User
  • 17.3. India Autogenous Vaccines Market Analysis
    • 17.3.1. Introduction
    • 17.3.2. Market Value Proportion Analysis by Market Taxonomy
    • 17.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 17.3.3.1. By Strain Type
      • 17.3.3.2. By End User
  • 17.4. Brazil Autogenous Vaccines Market Analysis
    • 17.4.1. Introduction
    • 17.4.2. Market Value Proportion Analysis by Market Taxonomy
    • 17.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 17.4.3.1. By Strain Type
      • 17.4.3.2. By End User

18. Market Structure Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Deep Dive
    • 19.2.1. Newport Laboratories, Inc. (Boehringer Ingelheim International GmbH)
      • 19.2.1.1. Overview
      • 19.2.1.2. Product Portfolio
      • 19.2.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.2.1.4. Sales Footprint
      • 19.2.1.5. Strategy Overview
        • 19.2.1.5.1. Marketing Strategy
        • 19.2.1.5.2. Product Strategy
        • 19.2.1.5.3. Channel Strategy
    • 19.2.2. Elanco Animal Health
      • 19.2.2.1. Overview
      • 19.2.2.2. Product Portfolio
      • 19.2.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.2.2.4. Sales Footprint
      • 19.2.2.5. Strategy Overview
        • 19.2.2.5.1. Marketing Strategy
        • 19.2.2.5.2. Product Strategy
        • 19.2.2.5.3. Channel Strategy
    • 19.2.3. Ceva (Ceva Biovac)
      • 19.2.3.1. Overview
      • 19.2.3.2. Product Portfolio
      • 19.2.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.2.3.4. Sales Footprint
      • 19.2.3.5. Strategy Overview
        • 19.2.3.5.1. Marketing Strategy
        • 19.2.3.5.2. Product Strategy
        • 19.2.3.5.3. Channel Strategy
    • 19.2.4. Cambridge Technologies
      • 19.2.4.1. Overview
      • 19.2.4.2. Product Portfolio
      • 19.2.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.2.4.4. Sales Footprint
      • 19.2.4.5. Strategy Overview
        • 19.2.4.5.1. Marketing Strategy
        • 19.2.4.5.2. Product Strategy
        • 19.2.4.5.3. Channel Strategy
    • 19.2.5. Hygieia Biological Laboratories
      • 19.2.5.1. Overview
      • 19.2.5.2. Product Portfolio
      • 19.2.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.2.5.4. Sales Footprint
      • 19.2.5.5. Strategy Overview
        • 19.2.5.5.1. Marketing Strategy
        • 19.2.5.5.2. Product Strategy
        • 19.2.5.5.3. Channel Strategy
    • 19.2.6. Dyntec s. r. o
      • 19.2.6.1. Overview
      • 19.2.6.2. Product Portfolio
      • 19.2.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.2.6.4. Sales Footprint
      • 19.2.6.5. Strategy Overview
        • 19.2.6.5.1. Marketing Strategy
        • 19.2.6.5.2. Product Strategy
        • 19.2.6.5.3. Channel Strategy
    • 19.2.7. Phibro Animal Health Corporation
      • 19.2.7.1. Overview
      • 19.2.7.2. Product Portfolio
      • 19.2.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.2.7.4. Sales Footprint
      • 19.2.7.5. Strategy Overview
        • 19.2.7.5.1. Marketing Strategy
        • 19.2.7.5.2. Product Strategy
        • 19.2.7.5.3. Channel Strategy
    • 19.2.8. Huvepharma, Inc.
      • 19.2.8.1. Overview
      • 19.2.8.2. Product Portfolio
      • 19.2.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.2.8.4. Sales Footprint
      • 19.2.8.5. Strategy Overview
        • 19.2.8.5.1. Marketing Strategy
        • 19.2.8.5.2. Product Strategy
        • 19.2.8.5.3. Channel Strategy
    • 19.2.9. Deltamune
      • 19.2.9.1. Overview
      • 19.2.9.2. Product Portfolio
      • 19.2.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.2.9.4. Sales Footprint
      • 19.2.9.5. Strategy Overview
        • 19.2.9.5.1. Marketing Strategy
        • 19.2.9.5.2. Product Strategy
        • 19.2.9.5.3. Channel Strategy
    • 19.2.10. AniCon Labor GmbH
      • 19.2.10.1. Overview
      • 19.2.10.2. Product Portfolio
      • 19.2.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.2.10.4. Sales Footprint
      • 19.2.10.5. Strategy Overview
        • 19.2.10.5.1. Marketing Strategy
        • 19.2.10.5.2. Product Strategy
        • 19.2.10.5.3. Channel Strategy
    • 19.2.11. ACE Laboratory Services (Apiam Animal Health)
      • 19.2.11.1. Overview
      • 19.2.11.2. Product Portfolio
      • 19.2.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.2.11.4. Sales Footprint
      • 19.2.11.5. Strategy Overview
        • 19.2.11.5.1. Marketing Strategy
        • 19.2.11.5.2. Product Strategy
        • 19.2.11.5.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology